No position yet. Refer to chart:) If you have any thoughts about this company, please leave in the comments:)
Selling the 47.5 put naked here below support as a potential precursor to a covered call, which I got filled for a .73 ($73)/contract credit. Basically, my thought process here is that I might want to covered call TEVA, but don't want to buy shares here at 53 (lower is better). I'll naturally watch price and roll the short put down and out for a credit should it...
Post-earnings, TEVA's implied volatility rank/implied volatility are still quite high, and the 47.5/60 short strangle goes for 1.58 ($158)/contract at the mid. Look to take it off at 50% max profit ... . Defined Risk Alternative: Sept 16th 42.5/47.5/60/65 iron condor, currently going for 1.13 ($113)/contract at the mid.
With broad market volatility ebbing, the place to sell premium is with earnings plays for now. Next week, look to put on options plays shortly before the earnings announcement to capitalize on post-announcement volatility contraction. This little fellahs currently look best for plays: LC: 5/9 (Monday) after market close. Due to the price of the underlying,...
Feel free to take a picture of this chart on the daily (for a perfect gap) and the 5 min chart as well in the early morning was FLAWLESS. Trying it here
TEVA had a couple of failed breakdowns below support, and appears to be moving upward.
Hello everyone, we have a potential pattern on this pair along with the structure . The targets are highlighted on the chart with two PRZ's. Good Luck For info: kevinsdhaliwal@hotmail.com Twitter: kevindhaliwal1 Instagram: AllTradingIdeas
TEVA has completed wave 3. for more info contact me to pavlicek@roklen.cz
Gilead has been in a heavy consolidation pattern around the $100 price level for the last 8 months and is about to breakout to the upside. The biotech sector as a whole is ready to start consolidating and some big M&A is about to happen. There has been lots of talk this weekend reinforcing arguments that GILD is getting ready to spend some of its $14 billion USD...
I am watching to Teva for long time when price was going in trading range. Teva break up the 2 years old resistance. Now it looks like trading range again. My target is around 62-63 USD per share.